JP2017532289A5 - - Google Patents

Download PDF

Info

Publication number
JP2017532289A5
JP2017532289A5 JP2017500952A JP2017500952A JP2017532289A5 JP 2017532289 A5 JP2017532289 A5 JP 2017532289A5 JP 2017500952 A JP2017500952 A JP 2017500952A JP 2017500952 A JP2017500952 A JP 2017500952A JP 2017532289 A5 JP2017532289 A5 JP 2017532289A5
Authority
JP
Japan
Prior art keywords
group
amino acid
proline
tryptophan
phenylalanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017500952A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017532289A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/065362 external-priority patent/WO2016005328A2/en
Publication of JP2017532289A publication Critical patent/JP2017532289A/ja
Publication of JP2017532289A5 publication Critical patent/JP2017532289A5/ja
Pending legal-status Critical Current

Links

JP2017500952A 2014-07-07 2015-07-06 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用 Pending JP2017532289A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462021308P 2014-07-07 2014-07-07
US62/021,308 2014-07-07
PCT/EP2015/065362 WO2016005328A2 (en) 2014-07-07 2015-07-06 IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID ß (Aß) AMINO ACID SEQUENCES AND USES THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020156999A Division JP2021001203A (ja) 2014-07-07 2020-09-18 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用

Publications (2)

Publication Number Publication Date
JP2017532289A JP2017532289A (ja) 2017-11-02
JP2017532289A5 true JP2017532289A5 (https=) 2018-08-16

Family

ID=53525183

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017500952A Pending JP2017532289A (ja) 2014-07-07 2015-07-06 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用
JP2020156999A Pending JP2021001203A (ja) 2014-07-07 2020-09-18 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用
JP2022192713A Pending JP2023036606A (ja) 2014-07-07 2022-12-01 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020156999A Pending JP2021001203A (ja) 2014-07-07 2020-09-18 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用
JP2022192713A Pending JP2023036606A (ja) 2014-07-07 2022-12-01 突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用

Country Status (11)

Country Link
US (2) US20160000891A1 (https=)
EP (1) EP3166969A2 (https=)
JP (3) JP2017532289A (https=)
CN (1) CN107074924A (https=)
AU (2) AU2015286824A1 (https=)
CA (1) CA2954031A1 (https=)
IL (1) IL249925B (https=)
MX (1) MX2017000094A (https=)
RU (1) RU2750268C2 (https=)
SG (1) SG11201700071WA (https=)
WO (1) WO2016005328A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20140240T4 (hr) 2005-11-30 2017-02-24 Abbvie Inc. Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba
US8987419B2 (en) * 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
EP3533803B1 (en) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antibodies
SG11201700071WA (en) * 2014-07-07 2017-02-27 Abbvie Deutschland IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID ß (Aß) AMINO ACID SEQUENCES AND USES THEREOF
EP3929584B1 (en) * 2016-09-06 2024-08-14 Fujirebio Inc. Method for measuring thyroglobulin
TW201812300A (zh) * 2016-09-13 2018-04-01 日商富士麗比歐股份有限公司 心肌肌鈣蛋白之測定方法及測定試藥
CN119264211A (zh) 2018-08-27 2025-01-07 瑞泽恩制药公司 拉曼光谱在下游纯化中的应用
CN110412294B9 (zh) * 2019-08-07 2023-05-26 深圳市新产业生物医学工程股份有限公司 蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法
US12352719B2 (en) 2019-09-20 2025-07-08 KYCERA AVX Components Corporation Somatic cell-based electrical biosensor
CN112851786B (zh) * 2019-11-12 2022-11-15 深圳市新产业生物医学工程股份有限公司 可溶性的Aβ1-42变体、Aβ1-42校准品及试剂盒
CN111793131A (zh) * 2020-05-11 2020-10-20 廊坊天光生物技术有限公司 一种用于检测血清中pf4含量的抗体对及其用途
WO2022164259A1 (ko) * 2021-01-28 2022-08-04 주식회사 에이브레인 신경 퇴행성 질환의 치료를 위한 유전자 요법
EP4230645A1 (en) * 2022-02-22 2023-08-23 Technische Universität München Peptidic inhibitors of amyloid self- and cross-assembly
CN117586370A (zh) * 2022-08-09 2024-02-23 深圳智源生物医药有限公司 强毒性淀粉样蛋白寡聚体及其用途
CN117700525B (zh) * 2024-02-05 2024-06-18 上海良润生物医药科技有限公司 一种多肽改造体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US8691224B2 (en) * 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
CN102203124A (zh) * 2008-07-25 2011-09-28 雅培制药有限公司 淀粉状蛋白β肽类似物,其寡聚物,用于制备的方法以及包括所述类似物或寡聚物的组合物,及其用途
US8987419B2 (en) * 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
EP3533803B1 (en) * 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antibodies
SG11201700071WA (en) * 2014-07-07 2017-02-27 Abbvie Deutschland IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID ß (Aß) AMINO ACID SEQUENCES AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2017532289A5 (https=)
RU2017103527A (ru) ИММУНОГЕННЫЕ ПРОДУКТЫ, ПОЛУЧЕННЫЕ НА ОСНОВЕ АМИНОКИСЛОТНЫХ ПОСЛЕДОВАТЕЛЬНОСТЕЙ МУТЕИНОВОГО АМИЛОИДА β(Aβ), И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2011529084A5 (https=)
JP2023540732A5 (https=)
JP2020537520A5 (https=)
JPH06501938A (ja) ペプチドよりなるhiv複製阻害剤
JP2011528561A5 (https=)
Zhang et al. Multiple-peptide conjugates for binding β-amyloid plaques of Alzheimer's disease
JP2011523550A5 (https=)
RU2013129815A (ru) Антигенсвязывающая молекула, способная многократно связываться с множеством антигенных молекул
RU2008120027A (ru) Анти-addl моноклональное антитело и его применение
JP2019502684A5 (https=)
RU2011100125A (ru) Соединения для лечения амилоидозов
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
WO2005025616A1 (ja) 抗体の用途
FI2897981T3 (fi) Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä
RU2012140954A (ru) Антитела, связывающиеся с протофибриллами, и их применение в методах терапии и диагностики болезни паркинсона, деменции, ассоциированной с образованием диффузных телец леви, и других а-синуклеинопатий
RU2010151725A (ru) Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их
RU2014102007A (ru) Методы предсказания, обнаружения и уменьшения неспецифической интерференции белков в способах анализа с использованием одиночных вариабельных доменов иммуноглобулинов
CA2501945A1 (en) Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
RU2011100126A (ru) Применение мимотопов для лечения бетта-амилоидозов
RU2013106270A (ru) Моноклональное антитело против addl и его применения
JP2013524774A5 (https=)
JP2009519895A5 (https=)
JP2016531546A5 (https=)